1型（胰岛素依赖型）糖尿病患者残余B细胞功能的患病率及其代谢后果 - Suppr

Suppr

超能文献

Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

作者信息

Madsbad S

出版信息

Diabetologia. 1983 Mar;24(3):141-7. doi: 10.1007/BF00250151.

DOI:10.1007/BF00250151

PMID:6341142

Abstract

摘要

相似文献

Prevalence of residual B cell function and its metabolic consequences in Type 1 (insulin-dependent) diabetes.

Diabetologia. 1983 Mar;24(3):141-7. doi: 10.1007/BF00250151.

Islet-cell antibodies and beta-cell function in insulin-dependent diabetics.

Diabetologia. 1980 Jan;18(1):45-7. doi: 10.1007/BF01228301.

Residual beta cell function in insulin-dependent diabetes: evaluation by circadian determination of C-peptide immunoreactivity.

J Endocrinol Invest. 1980 Apr-Jun;3(2):107-11. doi: 10.1007/BF03348235.

The relationship between residual insulin secretion and metabolic stability in type 1 (insulin dependent) diabetes.

Diabetologia. 1981 Aug;21(2):99-102. doi: 10.1007/BF00251274.

Importance of insulin absorption, subcutaneous blood flow, and residual beta-cell function in insulin therapy.

Acta Paediatr Scand Suppl. 1980;283:81-5. doi: 10.1111/j.1651-2227.1980.tb15323.x.

[Beta cell function in insulin-treated diabetes mellitus determined by C-peptide measurement].

Ugeskr Laeger. 1980 Jan 21;142(4):215-21.

B-cell function and islet cell and other organ-specific autoantibodies in relatives to insulin-dependent diabetic patients.

Acta Med Scand. 1983;213(3):199-203. doi: 10.1111/j.0954-6820.1983.tb03717.x.

Beta-cell function and metabolic control in insulin treated diabetics.

Acta Endocrinol (Copenh). 1980 Feb;93(2):196-200. doi: 10.1530/acta.0.0930196.

Correlation between fasting serum C-peptide and B cell insulin secretory capacity in diabetes mellitus.

Diabetologia. 1982 Apr;22(4):296. doi: 10.1007/BF00281310.

Insulin secretory reserve in insulin dependent patients at time of diagnosis and the first 180 days of insulin treatment.

Acta Endocrinol (Copenh). 1980 Nov;95(3):359-63. doi: 10.1530/acta.0.0950359.

引用本文的文献

Continuous stimulation of dual-function peptide PGLP-1-VP inhibits the morbidity and mortality of NOD mice through anti-inflammation and immunoregulation.

Sci Rep. 2021 Feb 11;11(1):3593. doi: 10.1038/s41598-021-83201-4.

Systemic TNFα correlates with residual β-cell function in children and adolescents newly diagnosed with type 1 diabetes.

BMC Pediatr. 2020 Sep 23;20(1):446. doi: 10.1186/s12887-020-02339-8.

Increased Proliferation of the Pancreatic Duct Gland Compartment in Type 1 Diabetes.

J Clin Endocrinol Metab. 2017 Jan 1;102(1):200-209. doi: 10.1210/jc.2016-3001.

Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.

Mol Endocrinol. 2016 May;30(5):543-56. doi: 10.1210/me.2015-1164. Epub 2016 Apr 6.

Efficacy and safety of the glucagon-like peptide-1 receptor agonist liraglutide added to insulin therapy in poorly regulated patients with type 1 diabetes--a protocol for a randomised, double-blind, placebo-controlled study: the Lira-1 study.

BMJ Open. 2015 Apr 2;5(4):e007791. doi: 10.1136/bmjopen-2015-007791.

Rationale use of GLP-1 receptor agonists in patients with type 1 diabetes.

Curr Diab Rep. 2013 Oct;13(5):663-8. doi: 10.1007/s11892-013-0404-x.

Possible role of GLP-1 and its agonists in the treatment of type 1 diabetes mellitus.

Curr Diab Rep. 2012 Oct;12(5):560-7. doi: 10.1007/s11892-012-0291-6.

Insulin action in adipose tissue in type 1 diabetes.

Int J Gen Med. 2011 Feb 22;4:153-7. doi: 10.2147/IJGM.S15809.

Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.

Diabetes. 2011 May;60(5):1599-607. doi: 10.2337/db10-1790. Epub 2011 Mar 25.

Beta cell function during rapamycin monotherapy in long-term type 1 diabetes.

Diabetologia. 2011 Feb;54(2):433-9. doi: 10.1007/s00125-010-1959-6. Epub 2010 Nov 3.

本文引用的文献

The biosynthesis of insulin and a probable precursor of insulin by a human islet cell adenoma.

Proc Natl Acad Sci U S A. 1967 Feb;57(2):473-80. doi: 10.1073/pnas.57.2.473.

Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.

Diabete Metab. 1981 Dec;7(4):265-9.

The significance of the portal insulin secretion in insulin dependent patients with residual beta-cell function: a safeguard against hormonal and metabolic derangement.

Clin Endocrinol (Oxf). 1982 Jun;16(6):605-13. doi: 10.1111/j.1365-2265.1982.tb03177.x.

The transient effect of strict glycaemic control on B cell function in newly diagnosed type 1 (insulin-dependent) diabetic patients.

Diabetologia. 1982 Jan;22(1):16-20. doi: 10.1007/BF00253863.

Effect of strict blood glucose control on residual B-cell function in insulin-dependent diabetics.

Diabetologia. 1981 May;20(5):530-4. doi: 10.1007/BF00252760.

Hormonal, metabolic, and cardiovascular responses to hypoglycemia in diabetic autonomic neuropathy.

Diabetes. 1981 Aug;30(8):626-33. doi: 10.2337/diab.30.8.626.

Diurnal profiles of intermediary metabolites in insulin-dependent diabetes and their relationship to different degrees of residual B-cell function.

Acta Diabetol Lat. 1981 Apr-Jun;18(2):115-21. doi: 10.1007/BF02098996.

[Preservation and regeneration of residual function of the beta cells in insulin-dependent diabetics].

Journ Annu Diabetol Hotel Dieu. 1981:87-96.

A prospective analysis of antibodies reacting with pancreatic islet cells in insulin-dependent diabetic children.

Diabetologia. 1981 Apr;20(4):471-4. doi: 10.1007/BF00253410.

Residual beta-cell function and islet cell antibodies in diabetic children.

Pediatr Res. 1981 Jan;15(1):62-5. doi: 10.1203/00006450-198101000-00015.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验